Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "magnetic resonance imaging (MRI) enhancement via EPR effect" refers to the use of the Enhanced Permeability and Retention (EPR) effect to improve the delivery and accumulation of MRI contrast agents—often nanoparticles—within tumor tissues. This approach leverages unique features of tumor vasculature, such as increased permeability and poor lymphatic drainage, allowing nano-sized agents to preferentially accumulate in tumors rather than normal tissues. By loading or conjugating MRI contrast agents onto nanocarriers that exploit the EPR effect, higher local concentrations of these agents can be achieved within tumors. This results in improved signal intensity and better delineation of tumor tissue during MRI scans.
Passive accumulation of nanoparticles in tumors due to leaky vasculature and poor lymphatic drainage (EPR effect), leading to increased concentration of MRI contrast agents and enhanced imaging.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Magnetic Resonance Imaging Enhancement via EPR effect.